✦ LIBER ✦

224 Molecular targeting of malignant pleural mesothelioma by c-Met and ROS modulation

✍ Scribed by Jagadeeswaran, R.; Zumba, O.; Kindler, H.L.; Salgia, R.

Book ID: 118573907
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 48 KB
Volume: 54
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(07)70300-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genetics of malignant pleural mesothelio

Genetics of malignant pleural mesothelioma: molecular markers and biologic targets

✍ Bueno, Raphael; Gordon, Gavin J. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 200 KB

Challenges and controversies in the diag

Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA

✍ Henderson, D. W.; Reid, G.; Kao, S. C.; van Zandwijk, N.; Klebe, S. 📂 Article 📅 2013 🏛 BMJ Publishing Group 🌐 English ⚖ 986 KB

Inhibition of Met/HGF receptor and angio

Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma

✍ Yoshinori Suzuki; Katsuya Sakai; Junko Ueki; Qing Xu; Takahiro Nakamura; Hideaki 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 707 KB

## Abstract NK4 exhibits two distinct biological actions: antagonistic inhibition of hepatocyte growth factor (HGF) through binding to the Met/HGF receptor, and antiangiogenic action through binding to perlecan. Here, the anti‐tumor effect of NK4 on malignant pleural mesothelioma was investigated.

174 Multicenter phase II trial of neoadj

174 Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin (PC) followed by extrapleural pneumonectomy (EPP) and radiation (RT) for malignant pleural mesothelioma (MPM)

✍ Krug, L.M.; Pass, H.I.; Rusch, V.W.; Kindler, H.L.; Sugarbaker, D.J.; Rosenzweig 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 46 KB

P-407 A multicenter phase 2 trial of neo

P-407 A multicenter phase 2 trial of neo-adjuvant pemetrexed pluscisplatin followed by extrapleural pneumonectomy (EPP) and radiation (RT) for malignant pleural mesothelioma (MPM)

✍ Krug, L.; Pass, H.; Rusch, V.; Sugarbaker, D.; Rosenzweig, K.; Friedberg, J.; Bl 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 150 KB